Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

SEPTEMBER 8, 2021

The partnership is reflected in the terms of the Binding Heads of Agreement between the Epsilon, THC Pharma (the Epsilon’s wholly owned subsidiary, and owner of the Southport Facility), Valens, and Valens Australia Pty Ltd (Valens’ wholly owned subsidiary) (the “ Agreement “).

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

JULY 8, 2021

We presume with that amount of money funding them they’ll have to supply the sort of results the federal government are looking for especially as a number of recent studies both in Australia and the US are beginning to indicate that measuring THC in the blood is a useless way of indicating impairment. Mirage News reports.

Medicine 98

Medicine Research and Development Safety THC 98

Cannabis Law Report

MAY 14, 2022

One of the largest and arguably sustainable customer bases, however, is consumers with some sort of health or therapeutic need for which they are unable to access medicinal cannabis. One potential consequence of the FSA’s drive to rein in the UK’s CBD industry is reduced access to the previously available wide range of products.

Access 52

Access CBD Research and Development Medicine 52

MMJ Recs

JULY 9, 2024

Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures. THC is primarily responsible for the psychoactive effects associated with marijuana, while CBD is known for its therapeutic properties without causing a “high.”

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

Veriheal

JANUARY 28, 2021

A study published in the Wiley-Blackwell Online Open looked into the significance of having a standard unit dose for cannabis research. Finding a standard unit of measurement for any cannabis compound will make it easier to consider legalization, administer, and improve research. The Importance of Standard Measurement.

THC 52

THC Research and Development Cannabinoids Safety 52

MMJ Recs

NOVEMBER 20, 2023

While there are over 100 different cannabinoids identified in cannabis, the two most well-known and widely studied are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the primary psychoactive compound in cannabis, responsible for the “high” or euphoric feeling associated with marijuana use.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Veriheal

DECEMBER 1, 2020

When many people think about cannabis, they think about THC and CBD. THC is the prominent intoxicating cannabinoid in cannabis that we know of. Recently the discovery of Delta-8-THC has taken control of the internet. Grinspoon goes on to estimate Delta-8-THC to be approximately 2/3 as potent as its cousin Delta 9.

THC 52

THC DEA Research and Development Cannabinoids 52

Cannabis Law Report

JANUARY 11, 2022

Ripple has incorporated a precise dose of cannabinol (CBN) and THC into the new line of products, allowing consumers to experience the benefits of an unadulterated cannabinoid product without any added sleep aids such as melatonin or valerian root, which can leave the consumer with an unwanted sedative feeling the next day.

THC 52

THC Clinical Trials Research and Development Sleep 52

PrestoDoctor

JANUARY 30, 2024

Connection between cannabis use and psychosis The connection between cannabis use and psychosis has been a topic of much research and debate. Studies have shown that individuals who use cannabis are at an increased risk of developing psychotic symptoms. THC primarily binds to the CB1 receptors in the brain.

Research and Development 52

Research and Development Treatment Conditions Education 52

The Cannigma

APRIL 12, 2023

The MoreBetter & CBDistillery CBN study CBN, or cannabinol , is a natural product of THC degradation; it can be found in aged, poorly stored cannabis plants and also in cannabis smoke. Like THC , CBN is a natural anti-inflammatory. What this means for CBN research These results are, in a word, impressive.

Sleep 135

Sleep Data Tincture Research and Development 135

Cannabis Law Report

OCTOBER 13, 2021

Whitmer signed House Bills 4517, 4745, and 4740-46 to regulate the THC derivative starting October 11, 2021. Many people are familiar with delta-9 THC, which is the active component in the legal marijuana plant that’s regulated in Michigan. Like CBD, delta-8 THC products are seen in grocery stores, gas stations and smoke shops.

THC 52

THC Research and Development Cannabinoids CBD 52

Project CBD

DECEMBER 21, 2022

We don’t make money by advertising products infused with sketchy “hemp-derived” intoxicants like delta-8, delta-10, HHC , THC -O , and other unregulated synthetic compounds. At Project CBD , we understand not everyone is in a position to pay to access our content. But if you are able, we really need your help.

Research and Development 130

Research and Development CBD Oil Sleep 130

Veriheal

NOVEMBER 9, 2023

A new 2023 study published in the journal Medical Cannabis and Cannabinoids revealed that using a THC/CBD spray can help significantly reduce chronic back and neck pain. This exciting development could have profound implications for how we approach managing this type of pain. How Does Cannabis Spray Work? The results were fascinating.

Treatment 109

Treatment Therapy Research and Development THC 109

Veriheal

AUGUST 15, 2022

This is according to a group of researchers from the University of New Mexico (UNM) , who recently teamed up with the creators of the Releaf App to investigate the true link between cannabis use and energy levels. The sessions were logged by a total of 1,224 people who had access to the app. Minor Cannabinoids vs. CBD and THC.

Treatment 96

Treatment Research and Development Sativa Cannabinoids 96

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. We are absolutely ecstatic,” George Hodgin, the CEO of the Castroville, California based Biopharmaceutical Research Co. BRC) told The Cannigma this week.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Veriheal

MARCH 21, 2022

At the end of November 2021, the CDC’s National Institute for Occupational Safety and Health (NIOSH) announced that there are deep-seated risks associated with driving a motor vehicle under the influence of cannabis’ psychotropic compound tetrahydrocannabinol (THC). Issues With Determining Cannabis Impairment.

Policy 98

Policy Blood Pressure Research and Development Concentrates 98

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Approved Cannabinoid-Based Medications.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

United Patients Group

JULY 29, 2024

Additionally, THC (tetrahydrocannabinol) offers psychoactive benefits that can alleviate anxiety and depression when used appropriately. For instance, incorporating CBD oil into your daily routine might provide long-term relief from persistent pain without the psychoactive effects associated with THC.

Research and Development 52

Research and Development Strains Chronic Pain Medicine 52

Cannabis Law Report

JULY 11, 2019

Australian medicinal cannabis developer THC Global (ASX: THC) has been granted a second manufacturing licence, this time for its large Southport facility, making it the largest licenced bio-pharma extraction facility in the Southern Hemisphere. Here’s the release in full. The competitive edge. Timeline to production.

Medicine 40

Medicine THC Research and Development Extraction 40

Cannabis Law Report

NOVEMBER 2, 2021

We got 51 hemp-derived Delta-8 THC products tested by an independent lab, and found high levels of Delta-9 THC in most of them. This is a well researched and detailed report and is, we suggest required reading. Illegal Limits of Delta-9 THC. Do Delta-8 THC Companies Verify Customers Ages? Table of Contents.

THC 96

THC CBD Legalization Vaping 96

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Approved Cannabinoid-Based Medications.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

SpeedWeed

JULY 28, 2021

The explosive, unregulated growth of delta-8 tetrahydrocannabinol (THC) is coming with a dangerous consequence: Poison control centers across the country are reporting a rise in calls from those who have ingested the cannabinoid. . THC limit,” he says. THC limit,” he says. The rest were off by 10.7% from the label.

Research and Development 52

Research and Development Packaging Hemp Cannabinoids 52

Cannabis Law Report

SEPTEMBER 7, 2021

The company imported approximately 50 kilograms of “Billy Buttons” THC (tetrahydrocannabinol) flower, approximately two months after finalising the $21.4 Named after an Australian wildflower, the medicine has a THC content of 16% and is available for sale in 15g packs through pharmacies nationwide. million acquisition.

Seed-To-Sale 103

Seed-To-Sale Supply Chain Research and Development Medicine 103

MMJ Recs

JULY 23, 2024

Women are more likely to develop RA than men, and the onset is usually between the ages of 30 and 60. Dietary factors, obesity, and certain medical conditions can increase the risk of developing gout. JIA can also affect the development of a child’s bones and joints. This dual action helps in managing arthritis symptoms.

Chronic Pain 52

Chronic Pain Research and Development Treatment Patients 52

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. THC is the psychoactive compound responsible for the “high” associated with marijuana use.

Law 52

Law Clinical Trials Dispensary Programs 52

Veriheal

MAY 3, 2022

A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Integrating Cannabis Into Mainstream Healthcare. .”

Consumption 109

Consumption Patients Research and Development Data 109

NORML

FEBRUARY 15, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? HI resident? KY resident?

Legislation 266

Legislation Decriminalization Access Patients 266

MMJ Recs

JULY 3, 2024

CBD, derived from the cannabis plant, has garnered attention for its potential therapeutic properties without the psychoactive effects commonly associated with tetrahydrocannabinol (THC). As interest in natural health remedies grows, CBD has become a focal point of research into its efficacy in managing anxiety and stress. What is CBD?

CBD 52

CBD Research and Development Clinical Trials THC 52

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Formula 1 THC is higher than CBD. Today (30 May) at 09.30

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

CannaMD

OCTOBER 6, 2020

As legalization opens new pathways for cannabis research, studies continue to expand the growing list of marijuana’s medical benefits. According to Eric Brown , lead researcher in the study at McMaster University: These findings suggest real therapeutic potential for cannabinoids as antibiotics. Is marijuana the next antibiotic?

Research and Development 116

Research and Development Marijuana Cannabinoids Conditions 116

MMJ Recs

JULY 11, 2024

It has shown effectiveness in helping individuals develop better sleep habits and manage insomnia symptoms without relying on medication. Key cannabinoids include tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabinol (CBN), each exerting unique effects on the ECS and potentially influencing sleep patterns.

Sleep 111

Sleep Treatment Research and Development Therapy 111